About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« China's Future | Main | You Don't See Many Names Starting with "Tellura-" »

May 13, 2010

Layoff at Takeda

Email This Entry

Posted by Derek

Takeda has announced cutbacks, and from what I'm seeing, the most concentrated of these are in the Chicago area. 28% of the 1300 jobs at the Deerfield headquarters are going, as are about 20% of the 840 jobs at the Lake Forest R&D center. Nothing at Takeda-San Diego or at Millennium in Cambridge, from what I've heard. The rest of the announced job losses (the majority, in fact) appear to be coming from the sales force.

Comments (7) + TrackBacks (0) | Category: Business and Markets


1. Brian on May 13, 2010 1:02 PM writes...

Ouch. I can see the Deerfield headquarters from the window of my (non pharma) workplace. They are just about finished building a new wing that looks like it will at 50% more square footage.

Permalink to Comment

2. You're Pfizered on May 13, 2010 1:35 PM writes...

Wondering if the folks from the Takeda-Abbott joint company, TAP, who moved over to Takeda are taking the brunt of this.

Permalink to Comment

3. Lisbeth Salander on May 13, 2010 3:47 PM writes...

A former colleague joined Takeda San Diego recently and passed along the comment that the company had never had a layoff in its 230-year history. Does anyone know if that is, um, was true?

Permalink to Comment

4. Mattoo on May 14, 2010 8:44 AM writes...

What kind of R&D work is done in IL? That's really too bad.

Permalink to Comment

5. SMILES on May 14, 2010 4:00 PM writes...

#3: your colleague is certainly fooled. I know several very experienced Med Chemists at Takeda San Diego were layoff just a few weeks ago.

Permalink to Comment

6. anonymous on May 14, 2010 10:20 PM writes...

Strange that the maker of Lupron/Lupron Depot
would do this right before the Autism One woo-
fest. See the Respectful Insolence blog for
details on the chemical castration protocols
certain doctors use to treat autistic patients.

Permalink to Comment

7. David Formerly Known as a Chemist on May 15, 2010 7:28 AM writes...

The Chicago facility is mainly development personnel. Regulatory, marketing, clinical, project management, etc. No lab facilities. Interesting timing, though, as they're constructing a brand new building right next to their existing one. I guess that new facility will feel pretty "roomy" for a while.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry